The Latest Trading Price of FDC Ltd is ₹ 368.75 as of 04 May 10:12
. The p/e ratio of FDC Ltd changed from 16 to 24.1 over 5 quarters. This represents a CAGR of 38.78%
The p/e ratio of Sanofi India Ltd changed from 30.8 to 0 over 7 quarters. This represents a CAGR of -100.00%
The market cap of FDC Ltd changed from ₹ 4822 crore to ₹ 6419 crore over 5 quarters. This represents a CAGR of 25.71%
The market cap of Sanofi India Ltd changed from ₹ 18578 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The revenue of FDC Ltd for the Dec '25 is ₹ 485.51 crore as compare to the Sep '25 revenue of ₹ 493.66 crore. This represent the decline of -1.65% The revenue of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of FDC Ltd for the Dec '25 is ₹ 52.29 crore as compare to the Sep '25 ebitda of ₹ 54.44 crore. This represent the decline of -3.95% The ebitda of Sanofi India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of FDC Ltd changed from ₹ 119.04 crore to ₹ 28.3 crore over 7 quarters. This represents a CAGR of -56.00%
The net profit of Sanofi India Ltd changed from ₹ 136.6 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00%
The dividend payout of FDC Ltd changed from 29.75 % to 29.75 % over 1 quarters. This represents a CAGR of 0.00%
The dividend payout of Sanofi India Ltd changed from 119.34 % to 0 % over 10 quarters. This represents a CAGR of -100.00%
.
About FDC Ltd
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
The Company is a prominent player in the Indian pharmaceutical industry, renowned for its expertise in developing specialised formulations.
It leads the market in sectors such as Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies.
It has established a global footprint in both domestic
and international market, standing as a beacon of excellence in pharmaceutical and consumer healthcare industry.
Promoted as a partnership firm in 1936 by the Late Anand Chandravarkar to import pharmaceutical dosage forms, specialised infant foods and surgical goods, FDC Limited was established on September 23, 1940.
About Sanofi India Ltd
Sanofi India Limited, was initially incorporated as 'Aventis Pharma Limited' in May, 1956.
The Company changed its name from Aventis Pharma Limited to Sanofi India Limited on May 11, 2012.
The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.
The Company is primarily engaged in the business of manufacturing and trading of drugs s and pharmaceuticals.
It has its own manufacturing facility at Goa.
FAQs for the comparison of FDC Ltd and Sanofi India Ltd
Which company has a larger market capitalization, FDC Ltd or Sanofi India Ltd?
Market cap of FDC Ltd is 5,937 Cr while Market cap of Sanofi India Ltd is 8,111 Cr
What are the key factors driving the stock performance of FDC Ltd and Sanofi India Ltd?
The stock performance of FDC Ltd and Sanofi India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for FDC Ltd and Sanofi India Ltd?
As of May 4, 2026, the FDC Ltd stock price is INR ₹364.7. On the other hand, Sanofi India Ltd stock price is INR ₹3522.25.
How do dividend payouts of FDC Ltd and Sanofi India Ltd compare?
To compare the dividend payouts of FDC Ltd and Sanofi India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.